Gemini Therapeutics Inc GMTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 03/05/21 EST
13.86quote price arrow down-0.29 (-2.05%)
Volume
411,075
52 week range
9.80 - 16.64

...

Loading . . .

KEY STATS

  • Open14.41
  • Day High14.41
  • Day Low12.81
  • Prev Close14.15
  • 52 Week High16.64
  • 52 Week High Date03/03/21
  • 52 Week Low9.80
  • 52 Week Low Date11/24/20
  • Market Cap627.86M
  • Shares Out45.30M
  • 10 Day Average Volume0.20M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-6.13
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Gemini Therapeutics Inc News

There is no recent news for this security.

Latest GMTX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Gemini Therapeutics, Inc., formerly FS Development Corp., is a clinical-stage precision medicine company. The Company is principally focused on developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration (AMD). The Company's lead product candidate, GEM103, is a recombinant form of the human complement factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health in patients with AMD. Its...
Address
300 One Kendall Square
3Rd Floor, Suite 4500
Cambridge, MA
02139
United States